Medical News

RSS

View News A-Z »

$UCL invest in Postnova Analytics fractionation system to develop nanoscale drug delivery vehicles$

UCL invest in Postnova Analytics fractionation system to develop nanoscale drug delivery vehicles

Postnova Analytics reports on the recent investment by the Department of Chemistry at University College London (UCL) in an AF2000 Field Flow Fractionation System to assist them in their development of novel nanoscale vehicles for drug delivery.

From Postnova Analytics 5 Dec 2016

Research unlocks potential new therapies for inflammatory diseases

Research unlocks potential new therapies for inflammatory diseases

Macrophages are frontline cells in our immune system. They detect microbial invaders and also tissue injury and then mount an appropriate response needed to clear the infection and repair the damaged tissue.

5 Dec 2016

New study examines parenting strategies that may influence children's disruptive behaviour

New study examines parenting strategies that may influence children's disruptive behaviour

A new study has examined the interaction between coparenting and coercive parenting in predicting children's disruptive behaviour.

5 Dec 2016

Milk from genetically-altered goats may trigger less severe allergic reactions, study finds

Milk from genetically-altered goats may trigger less severe allergic reactions, study finds

The presence of the allergen β-Lactoglobulin (BLG) in the milk of goats and other ungulates restricts the consumption of goat's milk by humans.

5 Dec 2016

New report estimates global burden of cancer cases and deaths in 2015

New report estimates global burden of cancer cases and deaths in 2015

In 2015, there were an estimated 17.5 million cancer cases around the globe and 8.7 million deaths, according to a new report from the Global Burden of Disease Cancer Collaboration published online by JAMA Oncology.

5 Dec 2016

New study urges caution in use of mannitol challenge test for asthma

New study urges caution in use of mannitol challenge test for asthma

A new study urges caution in the use of the mannitol challenge test for asthma in non-clinical settings.

5 Dec 2016

Research finds promising therapeutic target for recovery of ejaculation in men after spinal cord injury

Research finds promising therapeutic target for recovery of ejaculation in men after spinal cord injury

New research provides insights on how to restore the ability to ejaculate in men who are not able to do so.

5 Dec 2016

Bedfont Scientific clears FDA follow-up audit

Bedfont Scientific clears FDA follow-up audit

Bedfont, medical device manufacturer specialising in breath analysis, is pleased to announce that the FDA has completed a successful inspection at its premises.

From Bedfont® Scientific Ltd 5 Dec 2016

Bedfont Scientific signs OEM deal with Laborie for Gastrolyzer range of breath monitors

Bedfont Scientific signs OEM deal with Laborie for Gastrolyzer range of breath monitors

Laborie, has signed an OEM agreement with Bedfont Scientific for their Gastrolyzer range of hydrogen and methane breath monitors.

From Bedfont® Scientific Ltd 5 Dec 2016

Bedfont Scientific appoints Jason Smith as new Managing Director

Bedfont Scientific appoints Jason Smith as new Managing Director

Trevor Smith announced that Bedfont will be appointing Jason Smith, as the new Managing Director, with Trevor moving on to the position of Chairman.

From Bedfont® Scientific Ltd 5 Dec 2016

Bedfont introduces GastroCH4ECK Gastrolyzer to help detect gastrointestinal disorders

Bedfont introduces GastroCH4ECK Gastrolyzer to help detect gastrointestinal disorders

Bedfont Scientific has specialised in the design and manufacture of exhaled breath and gas monitoring instruments since 1976.

From Bedfont® Scientific Ltd 5 Dec 2016

Bedfont Scientific teams up with GPs to implement FeNO testing to improve asthma care

Bedfont Scientific teams up with GPs to implement FeNO testing to improve asthma care

Figures released from the 2014 National Records of Scotland show that 122 people died from an asthma attack the previous year.

From Bedfont® Scientific Ltd 5 Dec 2016

Bedfont Scientific’s Gastrolyzer range helps dietitians detect and treat dietary problems

Bedfont Scientific’s Gastrolyzer range helps dietitians detect and treat dietary problems

This year Dietitian Week takes place between 6-10 June, marking the 3rd annual awareness week for Dietitians.

From Bedfont® Scientific Ltd 5 Dec 2016

Bedfont Scientific donates over 50 Smokerlyzers to join battle against tobacco dependency

Bedfont Scientific donates over 50 Smokerlyzers to join battle against tobacco dependency

Bedfont Scientific, celebrating 40 years in business, has donated over 50 carbon monoxide breath monitors, famously known as the Smokerlyzer, to the ENSP.

From Bedfont® Scientific Ltd 5 Dec 2016

Bedfonts’ Smokerlyzer now integrated with SteriTouch technology

Bedfonts’ Smokerlyzer now integrated with SteriTouch technology

Bedfont who in 2016 are celebrating two important anniversaries, are revered as pioneers in the breath analysis market.

From Bedfont® Scientific Ltd 5 Dec 2016

Bedfont Scientific’s Gastrolyzer monitors can help detect IBS through simple breath test

Bedfont Scientific’s Gastrolyzer monitors can help detect IBS through simple breath test

April is IBS awareness month and for the IBS Network's 25th Anniversary show, they are highlighting IBS from the patient's perspective.

From Bedfont® Scientific Ltd 5 Dec 2016

Bedfont Scientific successfully passes first unexpected BSI audit

Bedfont Scientific successfully passes first unexpected BSI audit

Bedfont Scientific, is a medical device manufacturer that specialises in breath analysis devices which are used to help detect certain health conditions.

From Bedfont® Scientific Ltd 5 Dec 2016

ESS 2016: Bedfont Scientific launches new and improved ToxCO carbon monoxide breath monitor

ESS 2016: Bedfont Scientific launches new and improved ToxCO carbon monoxide breath monitor

Bedfont Scientific’s ToxCO monitor instantly diagnoses CO poisoning by analysing a breath sample from the patient to determine the level of CO in their blood.

From Bedfont® Scientific Ltd 5 Dec 2016

UL’s ‘Close Your Door’ pledge may increase victim survivability during fire

UL’s ‘Close Your Door’ pledge may increase victim survivability during fire

UL’s “Close Your Door” pledge aims to increase awareness of a new preventative measure that helps increase fire victim survivability.

5 Dec 2016

UL launches new tool to quantify global state of safety

UL launches new tool to quantify global state of safety

UL (Underwriters Laboratories), a global safety science company, today released The UL Safety Index, a new tool to quantify the relative state of safety across nearly 190 countries.

5 Dec 2016

Hi, I'm Azthena, you can trust me to find commercial scientific answers from News-Medical.net.

To start a conversation, please log into your AZoProfile account first, or create a new account.

Registered members can chat with Azthena, request quotations, download pdf's, brochures and subscribe to our related newsletter content.

A few things you need to know before we start. Please read and accept to continue.

Use of “Azthena” is subject to the terms and conditions of use as set out by OpenAI.
Content provided on any AZoNetwork sites are subject to the site Terms & Conditions and Privacy Policy.
Large Language Models can make mistakes. Consider checking important information.

I understand, and agree to receive occasional emails about Azthena such as usage tips and new feature announcements.

Please check the box above to proceed.

Great. Ask your question.

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.